These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3675957)

  • 21. Clinical significance of a dialysis membrane that can remove beta 2-microglobulin (beta 2m).
    Ono T; Iwamoto N; Kataoka H; Yamada S; Sakai Y; Kunitomo T
    ASAIO Trans; 1988; 34(3):342-5. PubMed ID: 3058179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of nocturnal hemodialysis on peripheral uremic neuropathy.
    Ghazan-Shahi S; Koh TJ; Chan CT
    BMC Nephrol; 2015 Aug; 16():134. PubMed ID: 26264143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDC puzzled over neurological disorders at Ala. dialysis unit. Impact of dialyzer age questioned.
    Neumann ME
    Nephrol News Issues; 1996 Nov; 10(11):9, 11. PubMed ID: 9025499
    [No Abstract]   [Full Text] [Related]  

  • 26. What is the role of expanded hemodialysis in renal replacement therapy in 2020?
    Perez-Garcia R; Alcazar-Arroyo R; de Sequera-Ortiz P
    Nefrologia (Engl Ed); 2021; 41(3):227-236. PubMed ID: 33685663
    [No Abstract]   [Full Text] [Related]  

  • 27. Biocompatibility and the clinical choice of dialysis membranes.
    Mujais SK; Ivanovich P; Bereza LA; Vidovich M
    Contrib Nephrol; 1995; 113():101-9. PubMed ID: 7712716
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of hemodialysis on somatosensory evoked potentials of medium and long latency].
    Rysz A; Gajkowski K
    Wiad Lek; 1992 Feb; 45(3-4):87-90. PubMed ID: 1413802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dietetic problems connected with amino acid depletion in renal insufficiency under dialysis therapy].
    Bucciante G; Costa A; Bernardi A; De Toni R; Costa C
    G Clin Med; 1980 May; 61(5):321-31. PubMed ID: 7450353
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients.
    Memoli B; Postiglione L; Cianciaruso B; Bisesti V; Cimmaruta C; Marzano L; Minutolo R; Cuomo V; Guida B; Andreucci M; Rossi G
    Kidney Int; 2000 Jul; 58(1):417-24. PubMed ID: 10886590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The technical evolution of hemodialysis].
    Man NK; Crosnier J
    Ann Med Interne (Paris); 1973 Feb; 124(2):81-4. PubMed ID: 4723745
    [No Abstract]   [Full Text] [Related]  

  • 32. Neurologic complications in chronic renal failure.
    Dinapoli RP; Johnson WJ
    Med Clin North Am; 1968 Jul; 52(4):845-51. PubMed ID: 4316068
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of two different dialysis membranes on leukocyte adhesion and aggregation.
    Hernandez MR; Palomo M; Fuste B; Carbó C; Collado S; Cases A; Escolar G
    Nephron Clin Pract; 2007; 106(1):c1-8. PubMed ID: 17347577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central and peripheral involvement in hemodialysed subjects: neurophysiological and nephrological relationships.
    Gambaro P; Bottacchi E; Camerlingo M; D'Alessandro G; Nebiolo PE; Aloatti S; Marchesan R; Mamoli A
    Ital J Neurol Sci; 1987 Feb; 8(1):31-4. PubMed ID: 3570720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of chronic kidney failure on electroneurographic changes in patients on hemodialysis treatment].
    Koteva A; Krivoshiev S
    Khirurgiia (Sofiia); 1989; 42(5):48-51. PubMed ID: 2560505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental studies on pathogenesis and progression of uremic neuropathy in rats. II. Is plasma myoinositol a uremic neurotoxin?
    Onishi S; Kawasaki T; Hamada K
    Bull Osaka Med Sch; 1986 Oct; 32(2):66-72. PubMed ID: 3427262
    [No Abstract]   [Full Text] [Related]  

  • 37. [Relationship between uremia polyneuropathy, uremic glucose metabolism disorder and severity of uremic intoxication in dialysis patients].
    Goubeaud G; Kunze K; Hohmann KH; Schütterle G; Biro G
    Verh Dtsch Ges Inn Med; 1974; 80():728-31. PubMed ID: 4454650
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of neurologic dysfunction in children with chronic renal disease by neurometrics.
    Polinsky M; Baird H; Gruskin A; Prebis J; Baluarte H; Rosenblum H; Grossman M
    Proc Clin Dial Transplant Forum; 1980; 10():299-301. PubMed ID: 6810350
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ways of intensification of hemodialysis therapy].
    Filiptsev PIa; Kirkhman VV; Timokhov VS
    Ter Arkh; 1988; 60(6):44-7. PubMed ID: 3206368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative evaluation of the dialysers used by patients with chronic kidney failure under hemodialysis treatment].
    Neĭmark MI
    Urol Nefrol (Mosk); 1986; (4):49-51. PubMed ID: 3765211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.